Home › Carcinoma polmonare a piccole cellule › New York
Studi clinici su Carcinoma polmonare a piccole cellule nello stato di New York
31 studi su Carcinoma polmonare a piccole cellule cercano partecipanti presso sedi nello stato di New York.
Città nello stato di New York
- New York City21 studi
- Queens9 studi
- Greenburgh6 studi
- Staten Island5 studi
- New Rochelle4 studi
- The Bronx4 studi
- Buffalo3 studi
Testo ufficiale dello studio (inglese)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Columbia University Medical Center, New York
- Memorial Sloan Kettering, New York
In reclutamentoFase 1/2
Età 12 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT04585750Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
- MSK Commack, Commack
- MSK Westchester, East White Plains
- Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy, Long Island City
- e altri 3
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07476287A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
- GSK Investigational Site, East Syracuse
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07099898A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- START New York, Lake Success
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07488676Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Memorial Sloan Kettering Cancer Center Head Neck Services, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 21 set 2026 · NCT05983432A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
- START New York, Lake Success
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 set 2026 · NCT07730021A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
- Roswell Park Cancer Institute, Buffalo
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 14 set 2026 · NCT07325136A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
- Stony Brook Cancer Center, Stony Brook
- Montefiore Medical Center, The Bronx
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 14 set 2026 · NCT07218146A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
- Roswell Park Cancer Institute ( Site 1107), Buffalo
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 set 2026 · NCT06780137AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, New York
In reclutamentoFase 1/2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 4 set 2026 · NCT07038343A Study of Armored CAR T Cells in People With Cancer
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
- e altri 1
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 set 2026 · NCT07783477Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- Cornell University - NewYork-Presbyterian/Weill Cornell Medical Center, New York
- White Plains Hospital, White Plains
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 set 2026 · NCT06712355Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
- Montefiore Medical Center- Montefiore Medical Park, The Bronx
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 ago 2026 · NCT07057791Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
- Memorial Sloan Kettering, New York
In reclutamentoFase 1/2
Età da 18 a 100 · Tutti i sessi · Aggiornato il 27 ago 2026 · NCT06726148A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
- Memorial Sloan Kettering Cancer Center (MSKCC), New York
- Icahn School of Medicine at Mount Sinai PRIME, New York
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 26 ago 2026 · NCT06892548A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
- NYU Langone Health, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 ago 2026 · NCT07488923Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
- New York University Cancer Institute, New York
In reclutamentoFase 1
Età da 18 a 99 · Tutti i sessi · Aggiornato il 21 ago 2026 · NCT07531095PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 12 ago 2026 · NCT04199741A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- e altri 1
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 11 ago 2026 · NCT06807632A Study of MGC026 in Participants With Advanced Solid Tumors
- START-New York Long Island, Lake Success
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 11 ago 2026 · NCT06242470A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- Clinical Research Alliance, Inc, Lake Success
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health Long Island, New York
- New York University Cancer Center - Laura and Isaac, New York
- e altri 1
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 6 ago 2026 · NCT06203210DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
- Montefiore Medical Center, The Bronx
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 lug 2026 · NCT05882058A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
- Columbia University Medical Center - Herbert Irving Pavilion, New York
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 lug 2026 · NCT07174583A Study of LY4175408 in Participants With Advanced Cancer
- Columbia University, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 giu 2026 · NCT07046923A Study of Hospital-at-Home for People Receiving Tarlatamab
- Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
- e altri 1
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 12 giu 2026 · NCT06957314A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
- Memorial Sloan Kettering Suffolk - Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- e altri 1
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 10 giu 2026 · NCT05419076Lung Cancer Biomarkers and Screening
- NYU Cancer Institute at New York University Medical Center, New York
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età 50 e oltre · Tutti i sessi · Aggiornato il 8 mag 2026 · NCT00301119Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
- Roswell Park Cancer Institute, Buffalo
- University of Rochester, Rochester
- Wilmot Cancer Institute at Webster, Webster
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 mar 2026 · NCT06769126VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Weill Cornell Medicine, Cornell University (site 126), New York
In reclutamentoFase 1/2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 11 dic 2025 · NCT03556228A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 107, New York
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 21 nov 2025 · NCT05914116Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)
- Icahn School of Medicine at Mount Sinai, New York
In reclutamentoStudio osservazionale
Età da 18 a 85 · Tutti i sessi · Aggiornato il 19 mar 2025 · NCT06717243Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.